AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12373371 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with load via pulley system
Number of subjects: 0
Study 9533391 — intervention group
Group type: EXPERIMENTAL
Intervention: Kanji (morphograms)
Number of subjects: 6
Study 9533391 — intervention group
Group type: EXPERIMENTAL
Intervention: Kana (syllabograms)
Number of subjects: 6
Study 9533391 — intervention group
Group type: EXPERIMENTAL
Intervention: Alphabet letters
Number of subjects: 6
Study 7541860 — intervention group
Group type: EXPERIMENTAL
Intervention: 560 mg estramustine phosphate daily for 6 weeks preoperatively
Number of subjects: 130
Study 7541860 — intervention group
Group type: COMPARATOR
Intervention: Immediate radical prostatectomy
Number of subjects: 130
Study 2612166 — intervention group
Group type: EXPERIMENTAL
Intervention: Formulation A
Number of subjects: 0
Study 2612166 — intervention group
Group type: COMPARATOR
Intervention: Formulation B
Number of subjects: 0
Study 849020 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (Bilarcil Bayer AG) at a dose rate of 7.5 mg/kg once per fortnight for three doses during therapy stage and four-weekly during prophylaxis stage.
Number of subjects: 0
Study 849020 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (Bilarcil Bayer AG)
Number of subjects: 0
Study 11590479 — intervention group
Group type: EXPERIMENTAL
Intervention: Arm training (AG)
Number of subjects: 15
Study 11590479 — intervention group
Group type: EXPERIMENTAL
Intervention: Leg training (LG)
Number of subjects: 15
Study 11590479 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 15
Study 29800423 — intervention group
Group type: EXPERIMENTAL
Intervention: Prescriptive implementation of DPA during instructional time (n = 88)
Number of subjects: 111
Study 29800423 — intervention group
Group type: COMPARATOR
Intervention: Nonprescriptive implementation of DPA during noninstructional time (n = 23)
Number of subjects: 111
Study 29078230 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital device (group D)
Number of subjects: 95
Study 29078230 — intervention group
Group type: COMPARATOR
Intervention: Water seal (group E)
Number of subjects: 95
Study 26278675 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD), n = 44
Number of subjects: 88
Study 26278675 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drainage, n = 44
Number of subjects: 88
Study 26278675 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed suction drainage (CSD)
Number of subjects: 88
Study 26278675 — intervention group
Group type: COMPARATOR
Intervention: No closed suction drainage
Number of subjects: 88
Study 25403298 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenotropil (12 weeks)
Number of subjects: 70
Study 25403298 — intervention group
Group type: COMPARATOR
Intervention: Pantogam active
Number of subjects: 70
Study 23018373 — intervention group
Group type: EXPERIMENTAL
Intervention: Smaller ring group
Number of subjects: 74
Study 20395896 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia with ropivacaine and sufentanil
Number of subjects: 120
Study 17906185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea diet (canned drained chickpeas, bread, and shortbread biscuits containing 30% chickpea flour)
Number of subjects: 27
Study 17906185 — intervention group
Group type: COMPARATOR
Intervention: Wheat-based diet (high-fibre wheat breakfast cereals and wholemeal bread)
Number of subjects: 27
Study 17906185 — intervention group
Group type: EXPERIMENTAL
Intervention: Chickpea diet
Number of subjects: 27
Study 17906185 — intervention group
Group type: COMPARATOR
Intervention: Lower-fibre wheat diet (low-fibre breakfast cereals and bread)
Number of subjects: 27
Study 16162713 — intervention group
Group type: EXPERIMENTAL
Intervention: Aqueous 0.03% nasal ipratropium
Number of subjects: 10
Study 16162713 — intervention group
Group type: COMPARATOR
Intervention: Normal saline solution placebo
Number of subjects: 10
Study 13679971 — intervention group
Group type: EXPERIMENTAL
Intervention: Grouped dosage of immunotherapy
Number of subjects: 0
Study 13679971 — intervention group
Group type: COMPARATOR
Intervention: Conventional dosage of immunotherapy
Number of subjects: 0
Study 10097931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lispro + NPH
Number of subjects: 56
Study 10097931 — intervention group
Group type: COMPARATOR
Intervention: Hum-R (Control)
Number of subjects: 56
Study 9124984 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpirome
Number of subjects: 123
Study 2065403 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral iron supplementation every day for three months (G1)
Number of subjects: 241
Study 2065403 — intervention group
Group type: COMPARATOR
Intervention: Placebo (G2)
Number of subjects: 241
Study 2065403 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplementation for anaemic infants (G3)
Number of subjects: 241
Study 6562280 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyacrilonitrile membrane
Number of subjects: 4
Study 6562280 — intervention group
Group type: COMPARATOR
Intervention: Cellulose hydrate, cuprophan, cellulose acetate, and polyacrilonitrile membranes
Number of subjects: 4
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) alone
Number of subjects: 68
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with home‐based listening (LH)
Number of subjects: 68
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with resonance frequency breathing (RFB)
Number of subjects: 68
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative improvisational music therapy (IIMT) with both enhancements (LH and RFB)
Number of subjects: 68
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-rated momentary depression level before every IIMT session
Number of subjects: 68
Study 31036058 — intervention group
Group type: EXPERIMENTAL
Intervention: Homework compliance in IIMT + LH
Number of subjects: 68
Study 30074418 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe hematologic toxicity (CTCAE grade 3–4)
Number of subjects: 873
Study 30074418 — intervention group
Group type: COMPARATOR
Intervention: Non-severe hematologic toxicity (CTCAE grade 0–2)
Number of subjects: 873
Study 26961928 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of folate
Number of subjects: 2525
Study 26961928 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of thiamin
Number of subjects: 2525
Study 26961928 — intervention group
Group type: EXPERIMENTAL
Intervention: High dietary intake of riboflavin
Number of subjects: 2525
Study 26961928 — intervention group
Group type: EXPERIMENTAL
Intervention: Folate and B vitamins
Number of subjects: 2525
Study 24446891 — intervention group
Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BV)
Number of subjects: 31
Study 24446891 — intervention group
Group type: EXPERIMENTAL
Intervention: Left ventricular only pacing (LV)
Number of subjects: 31
Study 24446891 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing (AP) with BV
Number of subjects: 31
Study 24446891 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial pacing (AP) with LV
Number of subjects: 31
Study 22732975 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CECT 7315/7316 (5*10^9 cfu/day) in 20 g powdered skim milk
Number of subjects: 60
Study 22732975 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum CECT 7315/7316 (5*10^8 cfu/day) in 20 g powdered skim milk
Number of subjects: 60
Study 22732975 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 g powdered skim milk)
Number of subjects: 60
Study 20088984 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine and 0.05% cetyl‐pyridinium chloride mouth rinse
Number of subjects: 47
Study 20088984 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouth rinse
Number of subjects: 47
Study 17401796 — intervention group
Group type: EXPERIMENTAL
Intervention: Spinal anesthesia using 0.5% hyperbaric bupivacain from L3-4 intervertebral space
Number of subjects: 50
Study 16365255 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy (1 to 6 multiples of MEDs)
Number of subjects: 14
Study 16365255 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy (2 to 6 MEDs)
Number of subjects: 14
Study 16365255 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted UV-B phototherapy
Number of subjects: 14
Study 12014782 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual-based bereavement group intervention
Number of subjects: 75
Study 12014782 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 75
Study 10594420 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture pretreatment
Number of subjects: 42
Study 10594420 — intervention group
Group type: COMPARATOR
Intervention: Standard anaesthetic without acupuncture
Number of subjects: 42
Study 7600477 — intervention group
Group type: EXPERIMENTAL
Intervention: Case management by an advanced practice nurse (APN)
Number of subjects: 78
Study 7600477 — intervention group
Group type: COMPARATOR
Intervention: Non-case management
Number of subjects: 78
Study 1977430 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol (200 mg twice daily)
Number of subjects: 13
Study 1977430 — intervention group
Group type: EXPERIMENTAL
Intervention: Xamoterol
Number of subjects: 13
Study 1977430 — intervention group
Group type: COMPARATOR
Intervention: Digoxin
Number of subjects: 13
Study 1977430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 502530 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression equation for males (Y=0.503+0.0269 X)
Number of subjects: 150
Study 502530 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression equation for females (Y=0.341+0.0291 X)
Number of subjects: 150
Study 502530 — intervention group
Group type: EXPERIMENTAL
Intervention: Total group regression equation
Number of subjects: 150
Study 502530 — intervention group
Group type: COMPARATOR
Intervention: Cooper's equation (Y=0.3138+0.0278 X)
Number of subjects: 150
Study 31800526 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediational Intervention for Sensitizing Caregivers (MISC) training emphasizing cognitive stimulation/enrichment
Number of subjects: 216
Study 31800526 — intervention group
Group type: COMPARATOR
Intervention: Health/nutrition/development program (UCOBAC)
Number of subjects: 216
Study 31209821 — intervention group
Group type: EXPERIMENTAL
Intervention: MSDE intervention (n=46)
Number of subjects: 89
Study 31209821 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=43)
Number of subjects: 89
Study 28620678 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle improvement program for 4 months
Number of subjects: 150
Study 28620678 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 150
Study 26433117 — intervention group
Group type: EXPERIMENTAL
Intervention: Blended electronic advanced life support (e-ALS) course
Number of subjects: 2848
Study 26433117 — intervention group
Group type: COMPARATOR
Intervention: Traditional face-to-face advanced life support course
Number of subjects: 2848
Study 26433117 — intervention group
Group type: EXPERIMENTAL
Intervention: e-ALS course
Number of subjects: 2848
Study 24491070 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intervention
Number of subjects: 137
Study 24491070 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only (treatment as usual)
Number of subjects: 137
Study 22971505 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A (gender-determined bent length)
Number of subjects: 246
Study 22971505 — intervention group
Group type: EXPERIMENTAL
Intervention: Group B (TMD-determined bent length)
Number of subjects: 246
Study 22971505 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (TID-determined bent length)
Number of subjects: 246
Study 22971505 — intervention group
Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 246
Study 19650856 — intervention group
Group type: EXPERIMENTAL
Intervention: Target hematocrit range of 42 +/- 3%
Number of subjects: 0
Study 19650856 — intervention group
Group type: COMPARATOR
Intervention: Partial correction in a range of 30 +/- 3%
Number of subjects: 0
Study 19650856 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal-hematocrit group in NHCT
Number of subjects: 0
Study 19650856 — intervention group
Group type: EXPERIMENTAL
Intervention: High doses of erythropoietic stimulating agents and/or intravenous iron
Number of subjects: 0
Study 16814449 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral continuous combined therapy (Group A, n = 31)
Number of subjects: 110
Study 16814449 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal sequential hormone replacement therapy (Group B, n = 30)
Number of subjects: 110
Study 16814449 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Group C, n = 30)
Number of subjects: 110
Study 14684777 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial Doppler (TCD)
Number of subjects: 57
Study 14684777 — intervention group
Group type: EXPERIMENTAL
Intervention: Near-infrared spectroscopy (NIRS)
Number of subjects: 57
Study 12003685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacologic treatment with antidepressants for patients with COPD and depression
Number of subjects: 0
Study 12003685 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary rehabilitation
Number of subjects: 0
Study 10092716 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine iontophoresis (1 mL of 2% lidocaine with 1:100,000 epinephrine)
Number of subjects: 47
Study 10092716 — intervention group
Group type: COMPARATOR
Intervention: Control (1 mL of 0.9% saline solution with 1:100,000 epinephrine)
Number of subjects: 47
Study 8548102 — intervention group
Group type: EXPERIMENTAL
Intervention: Generalized additive models
Number of subjects: 0
Study 8548102 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival models
Number of subjects: 0
Study 8548102 — intervention group
Group type: EXPERIMENTAL
Intervention: Binary outcome models
Number of subjects: 0
Study 2256875 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenytoin (anticonvulsant dose)
Number of subjects: 0
Study 2256875 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7362955 — intervention group
Group type: EXPERIMENTAL
Intervention: Single preoperative dose of cotrimoxazole and metronidazole
Number of subjects: 60
Study 7362955 — intervention group
Group type: COMPARATOR
Intervention: Multiple doses of cotrimoxazole and metronidazole for 5 days
Number of subjects: 60
Study 7362955 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose group
Number of subjects: 60
Study 7362955 — intervention group
Group type: COMPARATOR
Intervention: Multiple doses group
Number of subjects: 60
Study 7362955 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with transphincteric colo-anastomoses
Number of subjects: 60
Study 7362955 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with anastomosis from within the abdomen
Number of subjects: 60
Study 31512832 — intervention group
Group type: EXPERIMENTAL
Intervention: Alveolar ridge preservation after tooth extraction (Bio‐Oss bone powder implanted in alveolar fossa and fixed with surface free gingival graft suture)
Number of subjects: 30
Study 31512832 — intervention group
Group type: COMPARATOR
Intervention: No treatment after tooth extraction (Control group)
Number of subjects: 30
Study 27820930 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous angioplasty and stenting (PTAS) plus aggressive medical management (AMM)
Number of subjects: 451
Study 27820930 — intervention group
Group type: COMPARATOR
Intervention: Aggressive medical management (AMM) alone
Number of subjects: 451
Study 26073397 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE) 4 g/day
Number of subjects: 427
Study 26073397 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 427
Study 24616241 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity prevention program participation
Number of subjects: 557
Study 24616241 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer influence
Number of subjects: 557
Study 23002274 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermal protection (protective clothing)
Number of subjects: 12
Study 23002274 — intervention group
Group type: EXPERIMENTAL
Intervention: Powered air-purifying respirator (PAPR)
Number of subjects: 12
Study 23002274 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodiesel substitution (100% biodiesel)
Number of subjects: 12
Study 23002274 — intervention group
Group type: COMPARATOR
Intervention: Baseline (normal conditions)
Number of subjects: 12
Study 23002274 — intervention group
Group type: EXPERIMENTAL
Intervention: Application temperature of HMA
Number of subjects: 12
Study 19040797 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonyautoxin (50 micrograms) infiltrated in ten pain trigger points, 200 microlitres per site.
Number of subjects: 27
Study 18055959 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing patient-rated unmet need
Number of subjects: 101
Study 18055959 — intervention group
Group type: EXPERIMENTAL
Intervention: Reducing staff-rated unmet need
Number of subjects: 101
Study 15352982 — intervention group
Group type: EXPERIMENTAL
Intervention: Z-Dex (idarubicin and dexamethasone)
Number of subjects: 106
Study 15352982 — intervention group
Group type: COMPARATOR
Intervention: VAD (vincristine, adriamycin and dexamethasone)
Number of subjects: 106
Study 11264441 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient chemoreceptor stimuli (100% O(2), 15% O(2), or 3% CO(2))
Number of subjects: 46
Study 11716207 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (9 microg per inhalation, total cumulative dose of 27 microg)
Number of subjects: 20
Study 11716207 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 11716207 — intervention group
Group type: EXPERIMENTAL
Intervention: Formoterol (27 microg)
Number of subjects: 20
Study 9152292 — intervention group
Group type: EXPERIMENTAL
Intervention: Staple repair
Number of subjects: 88
Study 9152292 — intervention group
Group type: COMPARATOR
Intervention: Suture repair
Number of subjects: 88
Study 8263076 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-bicisate
Number of subjects: 25
Study 8263076 — intervention group
Group type: COMPARATOR
Intervention: [123I]IMP
Number of subjects: 25
Study 3297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine 1 g/day
Number of subjects: 164
Study 3297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 1.5 g/day
Number of subjects: 164
Study 3297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 2.5 g/day
Number of subjects: 164
Study 3297895 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylamine persilate (DAP) 0.5 g/day
Number of subjects: 164
Study 3297895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study 2035002 — intervention group
Group type: EXPERIMENTAL
Intervention: New organizational routine in the experimental group
Number of subjects: 65
Study 2035002 — intervention group
Group type: COMPARATOR
Intervention: Usual routines in the control group
Number of subjects: 65
Study 1156214 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa plus levodopa
Number of subjects: 37
Study 1156214 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus levodopa
Number of subjects: 37
Study 1156214 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbidopa plus levodopa (non-blind trial)
Number of subjects: 37
Study 31846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive and sustained vasodilation (n=386)
Number of subjects: 788
Study 31846016 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=402)
Number of subjects: 788
Study 31846016 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensive and sustained vasodilation
Number of subjects: 788
Study 31846016 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 788
Study 27777038 — intervention group
Group type: EXPERIMENTAL
Intervention: STAND
Number of subjects: 9
Study 27777038 — intervention group
Group type: EXPERIMENTAL
Intervention: CYCLE
Number of subjects: 9
Study 27777038 — intervention group
Group type: EXPERIMENTAL
Intervention: WALK
Number of subjects: 9
Study 27777038 — intervention group
Group type: COMPARATOR
Intervention: SIT
Number of subjects: 9
Study 27565118 — intervention group
Group type: COMPARATOR
Intervention: Completely Self-Guided (CSG) Internet-based program
Number of subjects: 296
Study 27565118 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Therapist-Guided (LITG) Internet-based program
Number of subjects: 296
Study 27565118 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved Treatment as Usual (iTAU)
Number of subjects: 296
Study 22962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpersonal Psychotherapy (IPT)
Number of subjects: 34
Study 22962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 34
Study 22962030 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential add-on treatment
Number of subjects: 34
Study 23117107 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga program (9-week, weekly 90-minute classes)
Number of subjects: 77
Study 23117107 — intervention group
Group type: COMPARATOR
Intervention: Self-care/exercise program
Number of subjects: 77
Study 19443276 — intervention group
Group type: EXPERIMENTAL
Intervention: Teplizumab (anti-CD3 mAb)
Number of subjects: 10
Study 17205018 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 142
Study 17205018 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 142
Study 15086924 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement taken with meal (1 g of calcium carbonate, 3 times/day)
Number of subjects: 32
Study 15086924 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplement taken at bedtime (3 g/day of calcium carbonate)
Number of subjects: 32
Study 12173297 — intervention group
Group type: EXPERIMENTAL
Intervention: Etanercept
Number of subjects: 0
Study 12173297 — intervention group
Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 0
Study 9391220 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 trials of tactile-thermal application (TTA)
Number of subjects: 0